Note: results can be filtered by year and/or keyword. To filter on year, select the appropriate year from the drop down menu. To filter on keyword, enter relevant term into open box, select appropriate keyword, and click "filter".
Op-eds & Articles
Full text of Article: Background: DR-TB in South Africa Tuberculosis is the leading cause of death in South Africa, and the country has a growing epidemic of drug-resistant tuberculosis (DR-TB). Every year, approximately 15,000 people are diagnosed with multi-drug resistant TB (MDR-TB), with a substantial proportion of these found to have more extensively drug resistant TB (XDR-TB).
Last updated 1 July 2014
Full text of Article: Phumeza Tisile, 23 years, reflects on her cure from XDR-TB at Lizo Nobanda TB Care Centre, Khayelitsha, South Africa on August 16, 2013. © Sydelle WIllow Smith
Last updated 29 August 2013
Full text of Article: Canada cannot allow the Trans-Pacific Partnership trade talks to undermine global access and innovation in medicines.
Last updated 19 August 2013
Full text of Article: Negotiations over pharmaceuticals patents at the Trans Pacific Partnership talks in Malaysia will decide whether many of the world's poor live in sickness or health, writes Jon Edwards. Jamal* is 15-years-old and lives in an orphanage for HIV positive children in a poor district of Kuala Lumpur, Malaysia. Like millions of children in the developing world, he faces a precarious future, living with a life threatening disease in a country where the drugs he needs to keep him well are among the most expensive in the world.
Last updated 19 August 2013
Full text of Article: The Trans Pacific Partnership (TPP) Agreement has been attracting a lot of public, media and political attention in Japan and has been one of the contested grounds of the recent Upper House elections. Politicians from all major parties, the Japan Medical Association and others have raised concerns about how the TPP could affect access to healthcare for patients in Japan. But what many people in Japan are not aware of is how the TPP could severely restrict access to affordable medicines in developing countries.
Last updated 23 July 2013
Full text of Article: In Mozambique, the fight against HIV/AIDS is being fought every day: about 11.5% of people in the coastal southern African country are living with the virus. Many of them suffer from complications related to their condition, such as Kaposi’s sarcoma, a type of cancer that causes painful and disfiguring lesions on the skin. In Maputo, the country’s capital, MSF is working alongside the Ministry of Health to treat patients suffering from these types of complications.
Last updated 18 July 2013
Full text of Article: Everyday, 600 children and 4,000 adults die of a treatable and manageable disease. After decades of struggle against HIV/AIDS there is still an urgent need to do more to stop people dying needlessly. Despite available and mostly affordable drugs, tools and models of care that work, is it acceptable that 1.7 million people succumb to the disease every year? I don’t think so.
Last updated 15 April 2013
Full text of Article: In May 2011, Bill Gates unveiled the Decade of Vaccines to the United Nations in Geneva. Aimed at reducing deaths due to vaccine-preventable diseases, and expanding the benefits of immunisation to all, particularly in low and middle-income countries, this initiative has catalysed a new momentum within the global health community.
Last updated 9 April 2013
Full text of Article: A liver cancer treatment is off-limits in the NHS due to its unjustifiably high price tag, but in India the same treatment is available for less than £100 a month. In this week's Scrubbing Up, Michelle Childs, of Medecins Sans Frontieres, questions why wealthy nations are not doing more to drive down medicine costs. Sorafenib tosylate is a drug for liver cancer patented by German pharmaceutical company Bayer and marketed as Nexavar.
Last updated 28 March 2013
Full text of Article: This week in Singapore, behind closed doors, government negotiators from 11 Pacific Rim countries meet for the 16th round of negotiations of the Trans-Pacific Partnership (TPP) trade agreement. The talks ended in Singapore yesterday (Wednesday) and the next round will be held in Peru in May .
Last updated 14 March 2013